View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters
Reset Filters

Nanotau

Luc Buée, Ph.D.
Lille, France
2023

ApoE Lipid Transport by ABCA7 Genetic Variants

Jamaine Davis, Ph.D.
Nashville, TN - United States
2023

SUMO2 Protein Replacement Therapy to Counteract Tau Toxicity in AD

Paul E. Fraser, Ph.D.
Toronto, Canada
2023

Targeting Tau Stress Granules for the Treatment of Tauopathies

Glenn Larsen, Ph.D. and Benjamin Wolozin, M.D., Ph.D.
Cambridge, MA - United States
2023

Enhancing Retromer Function: A Novel Therapeutic Strategy for Tauopathies

Gregory Petsko, Ph.D.
Boston, MA - United States
2023

Late-Stage Development of a PIKFYVE Antisense Oligonucleotide Treatment for FTD

Peter Sazani, Ph.D.
Monrovia, CA - United States
2023

Cerebrovascular endothelial cilia in Alzheimer's Disease and hypertension

Wissam AbouAlaiwi, Ph.D.
Toledo, OH - United States
2022

APP-dependent changes in vesicle refilling following Aß and tau elevation

Erica Acquarone, Ph.D.
New York, NY - United States
2022

Endothelial SOCS3 role in post-shock brain damage and cognitive impairment

Alejandro Adam, Ph.D.
Albany, NY - United States
2022

The role of community-level policing on the health for Black older adults

Paris Adkins-Jackson, Ph.D., MPH
New York, NY - United States
2022

Outcomes and quality of life for people with dementia facing surgery

Rachel Adler, Sc.D.
Boston, MA - United States
2022

Co-Therapy of Nilotinib and Lithium for Treating Alzheimer’s disease

Aida Adlimoghaddam, Ph.D.
Winnipeg, Canada
2022

Association Between Biomarkers of Chronic Stress and Cognition in Latinos

Paula Aduen, Ph.D.
Boston, MA - United States
2022

Microglia Regulation of Alzheimer’s Disease Pathology and Progression

Bahareh Ajami, Ph.D.
Portland, OR - United States
2022

The Bloom Social Therapeutic Horticultural,Healing-Garden Project for Elderly

Funmi Akindejoye
Ibadan, Nigeria
2022

Role of child gut microbiota on adult Alzheimer's disease susceptibility

Ziad Al Nabhani, Ph.D.
Bern, Switzerland
2022

Early microglia–neuron interactions in Alzheimer's Disease

Giulia Albertini, Ph.D.
Gent, Belgium
2022

Characterizing Neurocognitive and Social Health in Ecuador

Kuripacha Alcamari Tituana Vega, M.D.
Quito, Ecuador
2022

A New Prospect in Triggering Early Hyperexcitability in Alzheimer’s Disease

David Alcantara-Gonzalez, Ph.D.
Menands, NY - United States
2022

CGRP Pathways in Clinicopathogically -established Parkinson Disease

Athanasia Alexoudi, Ph.D.
Athens, Greece
2022

Engineered Decoy Viral Inhibitors (DEVi) to Prevent Tau Spread by LRP1

Gaya Amarasinghe, Ph.D.
St. Louis, MO - United States
2022

Health Outcomes of Transitional Space Design for Older Adults with Dementia

Diana Anderson, M.D., M. Arch
Boston, MA - United States
2022

Ancestry-specific effects of APOE on AD endophenotypes and risk factors

Shea J. Andrews, Ph.D.
New York, NY - United States
2022

Selective mTOR Inhibition to Treat Alzheimer's Disease

Zoltan Arany, M.D., Ph.D.
Philadelphia, PA - United States
2022

Role of Social Interaction and Physical Activity in Brain Health in FTD

Faheem Arshad, D.M.
Bengaluru, India
2022

Microglia Structure and Function in Tau Pathology and During Treatment

Alejandro Avila, Ph.D.
New York, NY - United States
2022

Influence of Structural Sexism and Racism on AD Risk

Justina Avila-Rieger, Ph.D.
New York, NY - United States
2022

Cellular events that shape microglial identity in Alzheimer's disease

Pinar Ayata, Ph.D.
New York, NY - United States
2022

Early Identification of Neurodegenerative Dementias in Psychiatry Clinics

Yavuz Ayhan, M.D.
Ankara, Turkey
2022

Impact of White Adipose Tissue on Tau Pathology in Transgenic Mice

David Baglietto-Vargas, Ph.D.
Málaga, Spain
2022

1 2 3 4 5 6 7 8 9 10... >|